References
- Bastiaannet E, Liefers GJ, de Craen AJ, et al. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat. 2010;124(3):801–807. doi:10.1007/s10549-010-0898-8
- Hamaker M, Lund C, Te Molder M, et al. Geriatric assessment in the management of older patients with cancer – a systematic review (update). J Geriatr Oncol. 2022;13(6):761–777. doi:10.1016/j.jgo.2022.04.008
- Maddams J, Utley M, Møller H. Projections of cancer prevalence in the United Kingdom, 2010–2040. Br J Cancer. 2012;107(7):1195–1202. doi:10.1038/bjc.2012.366
- Li M, Kim H, Sereika SM, Nissley TJ, Lingler JH. Willingness to participate in clinical research among individuals with cognitive impairment. Res Gerontol Nurs. 2022;15(2):76–84. doi:10.3928/19404921-20220131-01
- Hines LE, Murphy JE. Potentially harmful drug–drug interactions in the elderly: a review. Am J Geriatr Pharmacother. 2011;9(6):364–377. doi:10.1016/j.amjopharm.2011.10.004
- Brath H, Mehta N, Savage RD, et al. What is known about preventing, detecting, and reversing prescribing cascades: a scoping review. J Am Geriatr Soc. 2018;66(11):2079–2085. doi:10.1111/jgs.15543
- Mohamed MR, Ramsdale E, Loh KP, et al. Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: a systematic review and meta-analysis. Oncologist. 2020;25(1):e94–e108. doi:10.1634/theoncologist.2019-0406